Skip to main content

NASDAQ:DNLI Stock Forecast, Price Targets (Buy or Sell) | DNLI Denali Therapeutics Inc. Analyst Ratings



We do not assume future debt refinancing or the rolling over of CP, regardless of the company's perceived credit strength or issuer credit rating. For instance, even for investment-grade issuers, we do not assume future debt maturities are refinanced with potential uncommitted capital raises. We could, however, consider a shorter time horizon.

We estimate DNLI Denali Therapeutics Inc. stock forecast parameters by: Cross-Coupled Oscillators with Multiple Regression



DNLI Denali Therapeutics Inc. Stock Forecast (Buy or Sell) as of 11 May 2022 for (n+1y)

Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network with Cross-Coupled Oscillators and Multiple Regression. Machine Learning based stock forecast (n+1y) for DNLI Denali Therapeutics Inc. as below:

Time series to forecast n: 11 May 2022 for (n+1y)

x axis:Likelihood %
y axis:Potential Impact %
z axis:Color (yellow to green) Technical Analysis %


 *AC Investment Research | Legal Disclaimer | NYSE | NASDAQ | LSE | NSE |